Effect of Dexmedetomidine on the Duration of Pain Control in ESP Block for Breast Surgery
Status:
Recruiting
Trial end date:
2022-01-17
Target enrollment:
Participant gender:
Summary
Patients undergoing Partial or total mastectomy with axillary LN dissection will receive
prior to induction of general anaesthesia ESP block at T4 level at the same side of the
surgery. one group will receive ropivacaine 0.375% and the other will get ropivacaine 0.375%
with dexmedetomidine 0.5mcg/kg as an adjuvant. time to first narcotic requirement will be
documented and therefore an assessment of the duration of action of the block will be made